GenMark Diagnostics, Inc. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2014
Full year 2014 revenue is expected to be $30.6 million, an increase of 59% against 2013 base business revenue, which excludes former customer NMTC.
1st Jan change | Capi. | |
---|---|---|
+8.00% | 185B | |
+31.86% | 158B | |
+33.21% | 113B | |
+2.28% | 64.32B | |
+21.14% | 55.66B | |
+0.11% | 48.41B | |
-6.76% | 37.82B | |
+0.78% | 35.57B | |
+11.28% | 28.12B |